6/22/2007

The FDA approved the use of Pfizer's Lyrica to treat fibromyalgia, a condition marked by muscle pain and fatigue. Each year, as many as 6 million people in the U.S. are affected by the disease, which usually strikes women and causes long-lasting or chronic pain as well as muscle stiffness and tenderness.

Full Story:
NYTimes.com

Related Summaries